Hypertension, Vol 9, 598-606, Copyright © 1987 by American Heart Association
LD Van de Kar, JH Urban, MS Brownfield and WH Simmons
Previous studies have indicated that administration of the serotonin
releaser p-chloroamphetamine HCl produces a dose-dependent increase in
renin secretion through a blood-borne renin-releasing factor. The present
studies were designed to partially characterize this renin- releasing
factor using an in vitro kidney slice method for the bioassay of
renin-releasing activity. Plasma from p-chloroamphetamine-treated,
nephrectomized rats was used to obtain the renin-releasing factor, which
was fractionated by ultrafiltration into fractions of molecular weight
ranges of 1000 to 5000, 5000 to 10,000, and 10,000 to 20,000. The molecular
weight ranges of the renin-releasing factor was determined to be between
5000 and 10,000. Since previous studies have shown that lesions in the
hypothalamus prevent the effect of p- chloroamphetamine on renin secretion,
we tested whether a hypothalamic extract can release renin from kidney
slices. Addition of extracts of boiled rat hypothalamic tissue to the
kidney slices caused an increase in renin release. Addition of cerebellar
extracts produced a smaller increase in renin release, whereas addition of
pituitary extracts had no effect. Fractionation by ultrafiltration of
bovine hypothalamic extract revealed that the fraction with a molecular
weight range of 5000 to 10,000 possessed the highest renin-releasing
ability. The 1000 to 5000 (molecular weight) fraction possessed a sizeable
renin- releasing activity, but the 10,000 to 20,000 fraction had no renin-
releasing activity. Both bovine hypothalamus fractions (molecular weights
between 1000-5000 and 5000-10,000) and plasma fraction lost their
renin-releasing activity after digestion with pronase, suggesting that the
renin-releasing factor or factors are peptides. These results suggest that
a renin-releasing factor originate in the hypothalamus.
ARTICLES
Partial characterization of a renin-releasing factor from plasma and hypothalamus
This article has been cited by other articles:
![]() |
Y. Zhang, K. J. Damjanoska, G. A. Carrasco, B. Dudas, D. N. D'Souza, J. Tetzlaff, F. Garcia, N. R. S. Hanley, K. Scripathirathan, B. R. Petersen, et al. Evidence That 5-HT2A Receptors in the Hypothalamic Paraventricular Nucleus Mediate Neuroendocrine Responses to (-)DOI J. Neurosci., November 1, 2002; 22(21): 9635 - 9642. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Van de Kar, A. Javed, Y. Zhang, F. Serres, D. K. Raap, and T. S. Gray 5-HT2A Receptors Stimulate ACTH, Corticosterone, Oxytocin, Renin, and Prolactin Release and Activate Hypothalamic CRF and Oxytocin-Expressing Cells J. Neurosci., May 15, 2001; 21(10): 3572 - 3579. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, M. Sjoquist, O. Skott, E. M. Stricker, and A. F. Sved Oxytocin-induced renin secretion in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R226 - R230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Charloux, H. Otzenberger, C. Gronfier, E. Lonsdorfer-Wolf, F. Piquard, and G. Brandenberger Oscillations in Sympatho-Vagal Balance Oppose Variations in {delta}-Wave Activity and the Associated Renin Release J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1523 - 1528. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |